Details of the Drug

General Information of Drug (ID: DM06U6R)

Drug Name
ALKASAR-18
Synonyms NOAC; N4-Octadecyl-1-beta-D-arabinofuranosylcytosine; 1-(beta-D-Arabinofuranosyl)-4-(octadecylamino)-2(1H)-pyrimidinone
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 1/2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C27H49N3O5
Canonical SMILES
CCCCCCCCCCCCCCCCCCNC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)O
InChI
1S/C27H49N3O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-28-23-18-20-30(27(34)29-23)26-25(33)24(32)22(21-31)35-26/h18,20,22,24-26,31-33H,2-17,19,21H2,1H3,(H,28,29,34)/t22-,24-,25+,26-/m1/s1
InChIKey
HQHQCEKUGWOYPS-URBBEOKESA-N
Cross-matching ID
PubChem CID
133043
CAS Number
158233-67-1
TTD ID
D0WY0N

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004862)